40.70% 0.3587

アフターアワーズ： 1.16 -0.08 -6.45%

Briacell Therapeutics Corp (BCTX)

Briacell Therapeutics Corp (BCTX) 最新ニュース

Briacell Therapeutics Corp (BCTX)

Briacell Therapeutics Corp (BCTX) 最新ニュース

Understanding the Risks of Investing in BriaCell Therapeutics Corp (BCTX) - Knox Daily

A closer look at BCTX’s price-to-free cash flow ratio - US Post News

BriaCell Therapeutics Corp’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

BriaCell Therapeutics Corp [BCTX] stock Initiated by H.C. Wainwright analyst, price target now $25 - The DBT News

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Sees Significant Decline in Short Interest - Defense World

Deeper Dive: Understanding BriaCell Therapeutics Corp (BCTX) Through its Various Ratios - The Dwinnex

A new trading data show BriaCell Therapeutics Corp (BCTX) is showing positive returns. - SETE News

BriaCell Therapeutics Corp’s latest rating changes from various analysts - Knox Daily

Research Analysts Offer Predictions for BriaCell Therapeutics Corp.’s FY2024 Earnings (NASDAQ:BCTX) - Defense World

Brokers Set Expectations for BriaCell Therapeutics Corp.’s FY2024 Earnings (TSE:BCT) - Defense World

HC Wainwright Weighs in on BriaCell Therapeutics Corp.’s FY2029 Earnings (TSE:BCT) - Defense World

BriaCell Therapeutics target cut by H.C. Wainwright - Investing.com

BriaCell Therapeutics (CVE:BCT) Given New C$15.00 Price Target at HC Wainwright - Defense World

Oncolytics Biotech Inc - Baystreet.ca

BioLife Solutions, Inc. (NASDAQ:BLFS) CRO Garrie Richardson Sells 3,070 Shares - Defense World

Ra capital executives buy Bicara Therapeutics shares for $32.99m - Investing.com India

BriaCell Therapeutics Corp. - Baystreet.ca

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients - GlobeNewswire

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients - StockTitan

Cantor Fitzgerald Reiterates “Overweight” Rating for BridgeBio Pharma (NASDAQ:BBIO) - Defense World

Bridgeline Digital CEO purchases $2,600 in company stock By Investing.com - Investing.com UK

Goodwin Advises Bicara’s $362 Million Upsized Initial Public Offering - Goodwin Procter

Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity - Pharmaceutical Technology

Market Update: BriaCell Therapeutics Corp (BCTX) Sees Negative Movement, Closing at 0.49 - The Dwinnex

Holdings of BriaCell Therapeutics Corp (BCTX) are aligned with the stars - SETE News

1,905 Shares in BridgeBio Pharma, Inc. (NASDAQ:BBIO) Bought by Headlands Technologies LLC - Defense World

Bicara Therapeutics raises $362 million in Nasdaq debut - The Pharma Letter

The Potential Rise in the Price of BriaCell Therapeutics Corp (BCTX) following insiders activity - Knox Daily

Bicara Therapeutics Announces Closing of $362 Million - GlobeNewswire

How does BCTX’s price to cash per share ratio compare in the market? - US Post News

Brixmor price target raised to $28 from $27 at Evercore ISI - TipRanks

The Future of BriaCell Therapeutics Corp: Analyzing BCTX - The InvestChronicle

The Potential Rise in the Price of Brixmor Property Group Inc (BRX) following insiders activity - Knox Daily

Arizona State Retirement System Grows Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO) - Defense World

Brixmor stock hits 52-week high at $27.73 amid robust growth - Investing.com

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Sees Significant Increase in Short Interest - Defense World

Bicara Therapeutics Opens at $26.25 , Upsized IPO Priced at $18 By Investing.com - Investing.com Canada

Bicara Therapeutics Rises 39% in Debut on Nasdaq - MarketWatch

3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders - MedCity News

TPG-backed Bicara Therapeutics shares surge 46% in stellar market debut - MSN

BriaCell raises $8.5M following positive results for its experimental cancer therapy - The Business Journals

Bicara Therapeutics Opens at $26.25 , Upsized IPO Priced at $18 - Investing.com India

Financial Health Report: BriaCell Therapeutics Corp (BCTX)’s Ratios Tell a Tale - The Dwinnex

Biotech raises $315 million in IPO, surpassing $250M target - The Business Journals

Bicara Leads Trio of US Biotech IPOs Raising $703 Million - Bloomberg

Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering - ForexTV.com

Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering - StockTitan

BriaCell Completes $8.5 Million Share Offering - TipRanks

BriaCell Therapeutics Announces Closing of $8.5 Million Offering - GlobeNewswire

BriaCell Therapeutics Announces Closing of $8.5 Million Offering - StockTitan

H.C. Wainwright maintains Buy rating on BriaCell shares with steady price target - Investing.com

Wall Street Analyst Initiated BriaCell Therapeutics Corp [BCTX]. What else is Wall St. saying - The DBT News

Take off with BriaCell Therapeutics Corp (BCTX): Get ready for trading - SETE News

BriaCell Therapeutics (NASDAQ:BCTX) Receives Buy Rating from HC Wainwright - Defense World

BriaCell Therapeutics Corp (BCTX) receives a Buy rating from H.C. Wainwright - Knox Daily

BCTXBriacell Therapeutics Corp. Common Shares Latest Stock News & Market Updates - StockTitan

BriaCell sets price for $8.5 million common share offering - Investing.com India

BriaCell Therapeutics Shares Retreat From Earlier Surge After Stock Offering - MarketWatch

BriaCell Therapeutics Launches $8.5 Million Offering - TipRanks

BriaCell sets price for $8.5 million common share offering - Investing.com

BriaCell announces $8.5M common shares offering - TipRanks

BriaCell sets price for $8.5 million common share offering By Investing.com - Investing.com UK

BriaCell Therapeutics Announces $8.5 Million Offering - GlobeNewswire

BriaCell Therapeutics Announces $8.5 Million Offering - StockTitan

Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday - Yahoo Finance

BriaCell Therapeutics Corp (BCTX) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle

BriaCell Therapeutics Shares Double on Positive Trial News for Breast Cancer Treatment - MarketWatch

Dow Tumbles 350 Points; US Inflation Rate Slows In August - Benzinga

BriaCell reports OS data from Phase 2 study of Bria-IMT in breast cancer - TipRanks

BriaCell’s Breakthrough in Breast Cancer Survival Rates - TipRanks

BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer - GlobeNewswire

BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer - StockTitan

BCTXに似た銘柄